ALR2 inhibitors (Kanazawa/KUTLO-NITT)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameALR2 inhibitors (Kanazawa/KUTLO-NITT)
Drug Alias Namealdose reductase 2 inhibitors (Kanazawa/KUTLO-NITT)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldose reductase inhibitors
TargetsAldose reductase
Therapy Area/IndicationsDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKanazawa University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKanazawa University
Active IndicationsN/A
Inactive IndicationsDiabetes Complications

Other Information

ATC CodeN/A
Related LinksN/A